الإجهاد التأكسدي في داء السكري ودور مضادات الأكسدة في الحد من مضاعفاته

1. Forman, H. J., & Zhang, H. (2021). Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nature Reviews Drug Discovery, 20(9), 689-709. https://doi.org/10.1038/s41573-021-00233-1

2. Badawi, A., Klip, A., Haddad, P., Cole, D. E., Bailo, B. G., El-Sohemy, A., & Karmali, M. (2010). Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes, metabolic syndrome and obesity: targets and therapy, 173-186. https://doi.org/10.2147/dmso.s9089

3. Halliwell, B., & Gutteridge, J. M. (2015). Free radicals in biology and medicine. Oxford university press. https://doi.org/10.1093/acprof:oso/9780198717478.003.0002

4. Sindhi, V., Gupta, V., Sharma, K., Bhatnagar, S., Kumari, R., & Dhaka, N. (2013). Potential applications of antioxidants—A review. Journal of Pharmaceutical Research, 7, 828–835. https://doi.org/10.1016/j.jopr.2013.10.001

5. Federation, I. D. (2021). IDF Diabetes Atlas 2021. International Diabetes Federation. https://doi.org/10.1136/bmjdrc-2021-002122

6. Trujillo, J., & Haines, S. T. (2020). Diabetes mellitus. In J. T. DiPiro, G. C. Yee, L. M. Posey, S. T. Haines, T. D. Nolin, & V. L. Ellingrod (Eds.), Pharmacotherapy: A pathophysiologic approach (11th ed.). McGraw-Hill Education. https://doi.org/10.1345/aph.1l477

7. Ozougwu, C. J., Obimba, C. K., Belonwu, D. C., & Unakalamba, B. C. (2013). The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. Journal of Physiology and Pathophysiology, 4, 46–57. https://doi.org/10.5897/JPAP2013.0001

8. DeFronzo, R. A., Ferrannini, E., Groop, L., et al. (2015). Type 2 diabetes mellitus. Nature Reviews Disease Primers, 1, Article 15019. https://doi.org/10.1038/nrdp.2015.19

9. Chatterjee, S., Khunti, K., & Davies, M. J. (2017). Type 2 diabetes. The Lancet, 389, 2239–2251. https://doi.org/10.1016/S0140-6736(17)30058-2

10. Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., et al. (2017). Type 1 diabetes mellitus. Nature Reviews Disease Primers, 3, Article 17016. https://doi.org/10.1038/nrdp.2017.16 11. Zhao, M., Wang, S., Zuo, A., Zhang, J., Wen, W., Jiang, W., … & Wang, M. (2021). HIF-1α/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury. Cellular & Molecular Biology Letters, 26(1), 40. https://doi.org/10.1186/s11658-021-00283-2 12. Sharifi-Rad M., Lankatillake C., Dias D. A., Docea A. O., Mahomoodally M. F., Lobine D., et al. (2020). Impact of natural compounds on neurodegenerative disorders: from preclinical to pharmacotherapeutics. J. Clin. Med. 9:1061. https://doi.org/10.3390/jcm9041061 13. Sies, H., Belousov, V. V., Chandel, N. S., Davies, M. J., Jones, D. P., Mann, G. E., … & Winterbourn, C. (2022). Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nature reviews Molecular cell biology, 23(7), 499-515. https://doi.org/10.1038/s41580-022-00456-z 14. Apak, R., Calokerinos, A., Gorinstein, S., Segundo, M. A., Hibbert, D. B., Gülçin, İ., … & Arancibia-Avila, P. (2022). Methods to evaluate the scavenging activity of antioxidants toward reactive oxygen and nitrogen species (IUPAC Technical Report). Pure and Applied Chemistry, 94(1), 87-144. https://doi.org/10.1515/pac-2020-090

15. Aranda-Rivera, A. K., Cruz-Gregorio, A., Arancibia-Hernández, Y. L., Hernández-Cruz, E. Y., & Pedraza-Chaverri, J. (2022). RONS and oxidative stress: an overview of basic concepts. Oxygen, 2(4), 437-478. https://doi.org/10.3390/oxygen2040030

16. Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014). Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiological Reviews, 94(3), 909–950. https://doi.org/10.1152/physrev.00026.2013 17. Chaudhary, P., Singh, D., Swapnil, P., Meena, M., and Janmeda, P. (2023). Euphorbia neriifolia (Indian spurge tree): A plant of multiple biological and pharmacological activities. Sustainability 15(2), 1225. https://doi.org/10.3390/su15021225 18. Korczowska‑Łącka, I., Słowikowski, B., Piekut, T., Hurła, M., Banaszek, N., Szymanowicz, O., Jagodziński, P. P., Kozubski, W., Permoda‑Pachuta, A., & Dorszewska, J. (2023). Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases. Antioxidants, 12(10), 1811. https://doi.org/10.3390/antiox12101811 19. Kurutas, E. B. (2016). The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutrition Journal, 15(1):71. https://doi.org/10.1186/s12937-016-0186-5

20. Bouayed, J., & Bohn, T. (2010). Exogenous antioxidants—Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxidative medicine and cellular longevity, 3(4), 228–237. https://doi.org/10.4161/oxim.3.4.12858 21. Centers for Disease Control and Prevention. (2022, November 11). National diabetes statistics report. U.S. Department of Health and Human Services. https://doi.org/10.3886/icpsr09705.v2 22. Daghlas, S. A., & Mohiuddin, S. S. (2023). Biochemistry, Glycogen. In StatPearls. StatPearls Publishing. https://doi.org/10.2337/cd22-as01 23. Hill, M. A., Yang, Y., Zhang, L., et al. (2021). Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism, 119, Article 154766. https://doi.org/10.1016/j.metabol.2021.154766 24. DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018). Type 1 diabetes. Lancet, 391(10138), 2449–2462. https://doi.org/10.1016/S0140-6736(18)31320-5 25. American Diabetes Association. (2021). Standards of medical care in diabetes—2022: Abridged for primary care providers. Clinical Diabetes, 40(1). https://doi.org/10.2337/cd21-as01

26. Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., et al. (2020). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences, 21(17), 6275. https://doi.org/10.3390/ijms21176275 27. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H. P., Giardino, I., & Brownlee, M. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404(6779), 787–790. https://doi.org/10.1038/35008121 28. Styskal, J., Van Remmen, H., Richardson, A., & Salmon, A. B. (2012). Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models?. Free radical biology and medicine, 52(1), 46-58. https://doi.org/10.1016/j.freeradbiomed.2011.10.441

29. Cho, S. J., Roman, G., Yeboah, F., & Konishi, Y. (2007). The road to advanced glycation end products: a mechanistic perspective. Current medicinal chemistry, 14(15), 1653-1671. https://doi.org/10.2174/092986707780830989 30. Nagai, R., Shirakawa, J. I., Ohno, R. I., Moroishi, N., & Nagai, M. (2014). Inhibition of AGEs formation by natural products. Amino Acids, 46(2), 261-266. https://doi.org/10.1007/s00726-013-1487-z 31. Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865), 813-820. https://doi.org/10.1038/414813a

32. Scivittaro, V., Ganz, M. B., & Weiss, M. F. (2000). AGEs induce oxidative stress and activate protein kinase C-βII in neonatal mesangial cells. American Journal of Physiology-Renal Physiology, 278(4), F676-F683. https://doi.org/10.1152/ajprenal.2000.278.4.f676 33. Nishizuka, Y. (1995). Protein kinase C and lipid signaling for sustained cellular responses. The FASEB journal, 9(7), 484-496. https://doi.org/10.1096/fasebj.9.7.7737456 34. Robertson, R. P. (2004). Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. Journal of Biological Chemistry, 279(41), 42351-42354. https://doi.org/10.1074/jbc.r400019200 35. Figueroa-Romero, C., Sadidi, M., & Feldman, E. L. (2008). Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Reviews in Endocrine and Metabolic Disorders, 9(4), 301-314. https://doi.org/10.1007/s11154-008-9104-2 36. Morales-Gonzalez, J. A. (Ed.). (2013). Oxidative stress and chronic degenerative diseases: A role for antioxidants. BoD–Books on Demand.‏ https://doi.org/10.5772/45722

37. Schleicher, E. D., & Weigert, C. (2000). Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney international, 58, S13-S18. https://doi.org/10.1046/j.1523-1755.2000.07703.x 38. Caturano, A., D’Angelo, M., Mormone, A., Russo, V., Mollica, M. P., Salvatore, T., … & Sasso, F. C. (2023). Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications. Current Issues in Molecular Biology, 45(8), 6651-6666. https://doi.org/10.3390/cimb45080420

39. Fowler, M. J. (2008). Microvascular and macrovascular complications of diabetes. Clinical Diabetes, 26(2), 77-82. https://doi.org/10.2337/diaclin.26.2.77 40. Thomas, M. C. (2011). Advanced glycation end products. Contributions to Nephrology, 170, 66-74. https://doi.org/10.1159/000324945 41. American Diabetes Association. (2021). Standards of medical care in diabetes—2022: Abridged for primary care providers. Clinical Diabetes, 40(1). https://doi.org/10.2337/cd22-as01 42. Sheikh-Ali, M., Chehade, J. M., & Mooradian, A. D. (2011). The antioxidant paradox in diabetes mellitus. American Journal of Therapeutics, 18(3), 266–278. https://doi.org/10.1097/mjt.0b013e3181b7badf 43. Mayer-Davis, E. J., Costacou, T., King, I., Zaccaro, D. J., & Bell, R. A. (2002). Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care, 25(12), 2172–2177. https://doi.org/10.2337/diacare.25.12.2172

44. Cuerda C. Luengo L. M. MA Valero Vidal. A. Burgos R. Calvo F. L. et al. (2011). Antioxidants and diabetes mellitus: review of the evidence. Nutr Hosp 26(1), 68-78. https://doi.org/10.1055/s-0033-1333688 45. Garcia-Bailo B. El-Sohemy A. Haddad P. S. Arora P. Benzaied F. Karmali M. et al. (2011). Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress. Biologics 5, 7-19. https://doi.org/10.5772/47834 46. Jeffrey, S., Isaac Samraj, P., & Sundara Raj, B. (2022). Therapeutic benefits of alpha-lipoic acid supplementation in diabetes mellitus: a narrative review. Journal of dietary supplements, 19(4), 566-586. https://doi.org/10.1080/19390211.2021.2020387 47. Vakali, E., Rigopoulos, D., Carrillo, A. E., Flouris, A. D., & Dinas, P. C. (2022). Effects of alpha-lipoic acid supplementation on human diabetic nephropathy: A systematic review and meta-analysis. Current diabetes reviews, 18(6), 43-50. https://doi.org/10.2174/1573399817666210914103329 48. Akbaraly, T. N., Fontbonne, A., Favier, A., & Berr, C. (2008). Plasma carotenoids and onset of dysglycemia in an elderly population: results of the Epidemiology of Vascular Ageing Study. Diabetes Care, 31(7), 1355-1359. https://doi.org/10.2337/dc07-2113 49. Hozawa, A., Jacobs Jr, D. R., Steffes, M. W., Gross, M. D., Steffen, L. M., & Lee, D. H. (2006). Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. American journal of epidemiology, 163(10), 929-937. https://doi.org/10.1093/aje/kwj136 50. Roohbakhsh, A., Karimi, G., & Iranshahi, M. (2017). Carotenoids in the treatment of diabetes mellitus and its complications: A mechanistic review. Biomedicine & Pharmacotherapy, 91, 31-42. https://doi.org/10.1016/j.biopha.2017.04.057 51. Neyestani, T. R., Shariatzadeh, N., Gharavi, A., Kalayi, A., & Khalaji, N. (2007). Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with Type 2 diabetes mellitus: a possible role in the prevention of long-term complications. Journal of endocrinological investigation, 30(10), 833-838. https://doi.org/10.1007/bf03349226 52. Lem, D. W., Gierhart, D. L., & Davey, P. G. (2021). A systematic review of carotenoids in the management of diabetic retinopathy. Nutrients, 13(7), 2441. https://doi.org/10.3390/nu13072441 53. Moschos, M. M., Dettoraki, M., Tsatsos, M., Kitsos, G., & Kalogeropoulos, C. (2017). Effect of carotenoids dietary supplementation on macular function in diabetic patients. Eye and visión, 4(1), 23. https://doi.org/10.1186/s40662-017-0088-4 54. Behrouz, V., Sohrab, G., Hedayati, M., & Sedaghat, M. (2021). Inflammatory markers response to crocin supplementation in patients with type 2 diabetes mellitus: a randomized controlled trial. Phytotherapy Research, 35(7), 4022-4031. https://doi.org/10.1002/ptr.7124 55. Zhang, J., Chen, Y., Zou, L., Jin, L., Yang, B., Shu, Y., & Gong, R. (2023). Dose–response relationship between dietary antioxidant intake and diabetic kidney disease in the US adults with diabetes. Acta Diabetologica, 60(10), 1365-1375. https://doi.org/10.1007/s00592-023-02125-2

56. Ghorbani, A. (2017). Mechanisms of antidiabetic effects of flavonoid rutin. Biomedicine & Pharmacotherapy, 96, 305-312. https://doi.org/10.1016/j.biopha.2017.10.001 57. Bondonno, N. P., Dalgaard, F., Murray, K., Davey, R. J., Bondonno, C. P., Cassidy, A., … & Hodgson, J. M. (2021). Higher habitual flavonoid intakes are associated with a lower incidence of diabetes. The Journal of nutrition, 151(11), 3533-3542. https://doi.org/10.1093/jn/nxab269

58. Dinda, B., Dinda, M., Roy, A., & Dinda, S. (2020). Dietary plant flavonoids in prevention of obesity and diabetes. Advances in protein chemistry and structural biology, 120, 159-235. https://doi.org/10.1016/bs.apcsb.2019.08.006

59. Guo, X. F., Ruan, Y., Li, Z. H., & Li, D. (2019). Flavonoid subclasses and type 2 diabetes mellitus risk: a meta-analysis of prospective cohort studies. Critical reviews in food science and nutrition, 59(17), 2850-2862. https://doi.org/10.1080/10408398.2018.1476964 60. Yeon, J. Y., Bae, Y. J., Kim, E. Y., & Lee, E. J. (2015). Association between flavonoid intake and diabetes risk among the Koreans. Clinica Chimica Acta, 439, 225-230. https://doi.org/10.1016/j.cca.2014.10.04

61. Søndergård, S. D., Cintin, I., Kuhlman, A. B., Morville, T. H., Bergmann, M. L., Kjær, L. K., … & Larsen, S. (2021). The effects of 3 weeks of oral glutathione supplementation on whole body insulin sensitivity in obese males with and without type 2 diabetes: a randomized trial. Applied Physiology, Nutrition, and Metabolism, 46(9), 1133-1142. https://doi.org/10.1139/apnm-2020-1099 62. Kalamkar, S., Acharya, J., Kolappurath Madathil, A., Gajjar, V., Divate, U., Karandikar-Iyer, S., … & Ghaskadbi, S. (2022). Randomized clinical trial of how long-term glutathione supplementation offers protection from oxidative damage and improves HbA1c in elderly type 2 diabetic patients. Antioxidants, 11(5), 1026. https://doi.org/10.3390/antiox11051026

63. To, K., Cao, R., Yegiazaryan, A., Owens, J., Nguyen, T., Sasaninia, K., … & Venketaraman, V. (2021). Effects of oral liposomal glutathione in altering the immune responses against Mycobacterium tuberculosis and the Mycobacterium bovis BCG strain in individuals with type 2 diabetes. Frontiers in Cellular and Infection Microbiology, 11, 657775. https://doi.org/10.3389/fcimb.2021.657775